Open Citizen Science Open Mind
← All news

2026-02-14 · Paper · Translational Psychiatry 16, 160

Electrophysiological effects of psilocybin co-administered with midazolam

Sutherland M, Nicholas C, Lennertz R, Wenthur C and others

Illustration: A trace that grows more varied from left to right, under a rising curve.
Editorial illustration, not data.

With a sedative given alongside psilocybin, brain-signal complexity still rose as the psychedelic effects came on.

Psilocybin was given together with a sedative that blunts memory. Early on, when mainly the sedative was acting, the EEG looked sedated. As the psychedelic took hold over six hours, complexity rose and power fell, and these changes tracked people's ratings of altered experience better than ratings of sedation.

Oral psilocybin 25 mg plus IV midazolam, high-density EEG. At 15-30 min (midazolam at target, psilocybin likely not): higher beta power, lower spectral exponent. Over the next six hours: higher normalised LZC and spectral exponent, lower broadband power. OAA/S sedation scores improved model fits for alpha power; ASC items improved fits for LZCn and spectral exponent. Small open-label pilot. Preprint bioRxiv 10.1101/2025.07.25.666887.

What we do with it

A case where complexity and the spectral exponent move together under a drug that changes experience. Our test asks whether complexity adds anything once the exponent is known. Planned

Read the original. Source checked against the original.